Metformin (MF) in the prevention of hyperglycemia (HG) in patients (pts) with PIK3CA-mutated, hormone receptor (HR) [+]/HER2[-] advanced breast cancer (ABC) treated with alpelisib (ALP) plus fulvestrant (F): METALLICA

Llombart Cussac, A.Perez-Garcia, J. M.Blanch, S.Tolosa, P.Ruiz Borrego, M.Gion Cortes, M.Fernadez, A.Urruticoechea, A.Galve, E.Cueva Banuelos, J. F.Ponce, J.Alonso, J. L.Capelan, M.Martinez, E.Bermejo De Las Heras, B.Rojas, B.Martos, T.Lopez, A.Gomez-Peralta, F.Cortes, J.2025-01-072025-01-072021-05-080923-7534https://hdl.handle.net/10668/27223enMetformin (MF) in the prevention of hyperglycemia (HG) in patients (pts) with PIK3CA-mutated, hormone receptor (HR) [+]/HER2[-] advanced breast cancer (ABC) treated with alpelisib (ALP) plus fulvestrant (F): METALLICAconference outputopen access10.1016/j.annonc.2021.03.1431569-8041http://www.annalsofoncology.org/article/S0923753421010218/pdf648924400133